Joaquim Ferreira

Citée par

	Toutes	Depuis 2016
Citations	15706	9182
indice h	59	46
indice i10	223	191

2200

1100

550

1650

20012002200320042005200620072008200920102011201220132014201520162017201820192020202142 96 106 107 179 277 308 314 436 484 584 603 753 833 1015 1343 1600 1761 1740 2171 501

Coauteurs

Olivier RASCOLUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)Adresse e-mail validée de univ-tlse3.fr
João CostaFaculdade de Medicina da Universidade de LisboaAdresse e-mail validée de medicina.ulisboa.pt
Werner PoeweProfessor NeurologieAdresse e-mail validée de i-med.ac.at
Fausto PintoProfessor of Cardiology, Lisbon University Medical SchoolAdresse e-mail validée de medicina.ulisboa.pt
Filipe Brogueira RodriguesClinical research fellow, UCL Huntington's Disease Centre, UCL Queen Square Institute of NeurologyAdresse e-mail validée de ucl.ac.uk
Angelo AntoniniUniversity of PaduaAdresse e-mail validée de unipd.it
Gonçalo S DuarteLaboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de LisboaAdresse e-mail validée de edu.ulisboa.pt
Bastiaan R. BloemProfessor of movement disorders neurology, Radboudumc, Nijmegen, the NetherlandsAdresse e-mail validée de radboudumc.nl
Alexandre Castro CaldasCentro de Investigação Interdisciplinar em Saúde - Instituto de Ciências da Saúde - UniversidadeAdresse e-mail validée de ics.lisboa.ucp.pt
christine Brefel-courbonMCU PH, Neuropharmacologie, CHU Toulouse; TONIC (INSERM UT3); TMBI Univ ToulouseAdresse e-mail validée de univ-tlse3.fr
Tiago Fleming OuteiroUniversity Medical Center Goettingen, Goettingen, GermanyAdresse e-mail validée de gwdg.de
Anette SchragUniversity College LondonAdresse e-mail validée de doctors.org.uk
Ricardo M FernandesFaculty of Medicine, University of LisbonAdresse e-mail validée de campus.ul.pt
Raquel Bouça-MachadoPhD student, Lisbon Faculty of MedicineAdresse e-mail validée de campus.ul.pt
Carlo ColosimoSanta Maria University Hospital, Terni, ItalyAdresse e-mail validée de uniroma1.it
David J BurnProfessor of Movement Disorder Neurology, Newcastle UniversityAdresse e-mail validée de ncl.ac.uk
Pierre PayouxUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), TMBI (Univ. Toulouse)Adresse e-mail validée de inserm.fr
Claudio DavidMedicina LisboaAdresse e-mail validée de campus.ul.pt
Vidailhet MarieDepartment of Neurology Salpetriere hospital, ICM, Sorbonne Université, Paris, FranceAdresse e-mail validée de psl.aphp.fr
Mamede de CarvalhoFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, PortugalAdresse e-mail validée de fm.ul.pt

Joaquim Ferreira

Faculdade de Medicina, Universidade de Lisboa

Adresse e-mail validée de medicina.ulisboa.pt - Page d'accueil

Parkinson's disease Huntington Systematic Review Pharmacology Movement Disorders


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008	1207	2008
How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor ED Louis, JJ Ferreira Movement Disorders 25 (5), 534-541, 2010	703	2010
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease A Di Fonzo, CF Rohé, J Ferreira, HF Chien, L Vacca, F Stocchi, L Guedes, ... The Lancet 365 (9457), 412-415, 2005	573	2005
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ... European journal of neurology 20 (1), 16-34, 2013	437	2013
Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of P arkinson's disease JJ Ferreira, R Katzenschlager, BR Bloem, U Bonuccelli, D Burn, ... European journal of neurology 20 (1), 5-15, 2013	417	2013
Corticosteroids for Bell's palsy (idiopathic facial paralysis) RA Salinas, G Alvarez, F Daly, J Ferreira Cochrane Database of Systematic Reviews, 2010	417	2010
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease A Di Fonzo, HF Chien, M Socal, S Giraudo, C Tassorelli, G Iliceto, ... Neurology 68 (19), 1557-1562, 2007	329	2007
Limitations of current Parkinson's disease therapy O Rascol, P Payoux, F Ory, JJ Ferreira, C Brefel‐Courbon, JL Montastruc Annals of Neurology: Official Journal of the American Neurological …, 2003	313	2003
Quantitative wearable sensors for objective assessment of Parkinson's disease W Maetzler, J Domingos, K Srulijes, JJ Ferreira, BR Bloem Movement Disorders 28 (12), 1628-1637, 2013	258	2013
Sleep attacks and Parkinson's disease treatment JJ Ferreira, M Galitzky, JL Montastruc, O Rascol The Lancet 355 (9212), 1333-1334, 2000	233	2000
DYSBOT: a single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin … C Sampaio, JJ Ferreira, F Simões, MJ Rosas, M Magalhães, AP Correia, ... Movement disorders 12 (6), 1013-1018, 1997	231	1997
Dopamine agonist therapy in early Parkinson's disease R Stowe, N Ives, CE Clarke, J Ferreira, RJ Hawker, L Shah, K Wheatley, ... Cochrane Database of Systematic Reviews, 2008	229	2008
Botulinum toxin type A therapy for blepharospasm J Costa, CC Espírito‐Santo, AA Borges, J Ferreira, MM Coelho, P Moore, ... Cochrane Database of Systematic Reviews, 2004	220*	2004
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease M Martins, A Rosa, LC Guedes, BV Fonseca, K Gotovac, S Violante, ... PloS one 6 (10), e25443, 2011	210	2011
Therapeutic interventions for symptomatic treatment in Huntington's disease T Mestre, J Ferreira, MM Coelho, M Rosa, C Sampaio Cochrane Database of Systematic Reviews, 2009	210	2009
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations B Högl, I Arnulf, C Comella, J Ferreira, A Iranzo, B Tilley, C Trenkwalder, ... Movement Disorders 25 (16), 2704-2716, 2010	201	2010
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor S Goldwurm, A Di Fonzo, EJ Simons, CF Rohe, M Zini, M Canesi, S Tesei, ... Journal of medical genetics 42 (11), e65-e65, 2005	199	2005
Botulinum toxin type A therapy for cervical dystonia J Costa, CC Espírito‐Santo, AA Borges, J Ferreira, MM Coelho, P Moore, ... Cochrane Database of Systematic Reviews, 2005	186	2005
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease A Di Fonzo, C Tassorelli, M De Mari, HF Chien, J Ferreira, CF Rohé, ... European journal of human genetics 14 (3), 322-331, 2006	182	2006
Late-stage Parkinson disease M Coelho, JJ Ferreira Nature Reviews Neurology 8 (8), 435-442, 2012	173	2012

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Importer un PDF

Suivre les mises à jour de cet auteur

Citée par

Coauteurs